Current and future contrast agents

被引:30
作者
Grayburn, PA [1 ]
机构
[1] Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75235 USA
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2002年 / 19卷 / 03期
关键词
contrast echocardiography; microbubbles; ultrasound;
D O I
10.1046/j.1540-8175.2002.00259.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article focuses on current and new contrast agents for opacification of left-sided cardiac chambers and myocardium after intravenous injection. The first generation of contrast agents, such as agitated saline, hydrogen peroxide, indocyanine green dye, and iodinated contrast, required aortic or intracoronary injection to opacify the left heart. Second generation agents, such as sonicated 5% human albumin-containing air bubbles, were capable of transpulmonary passage but often failed to produce adequate imaging of the left heart. Newer agents containing fluorocarbon gases within albumin, surfactant, lipid, or polymer shells hold great promise to achieve myocardial perfusion via intravenous injection. The characteristics of these agents and the results of early clinical trials will be discussed.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 42 条
[1]   Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen(R)): Its efficacy and side effects [J].
Beppu, S ;
Matsuda, H ;
Shishido, T ;
Matsumura, M ;
Kiyatake, K .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (01) :11-24
[2]   Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent [J].
Broillet, A ;
Puginier, J ;
Ventrone, R ;
Schneider, M .
INVESTIGATIVE RADIOLOGY, 1998, 33 (04) :209-215
[3]   Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent - Results of a phase III multicenter trial [J].
Cohen, JL ;
Cheirif, J ;
Segar, DS ;
Gillam, LD ;
Gottdiener, JS ;
Hausnerova, E ;
Bruns, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :746-752
[4]  
Correas JM, 1996, CLIN RADIOL, V51, P11
[5]   OPACIFICATION AND BORDER DELINEATION IMPROVEMENT IN PATIENTS WITH SUBOPTIMAL ENDOCARDIAL BORDER DEFINITION IN ROUTINE ECHOCARDIOGRAPHY - RESULTS OF THE PHASE-III ALBUNEX MULTICENTER TRIAL [J].
CROUSE, LJ ;
CHEIRIF, J ;
HANLY, DE ;
KISSLO, JA ;
LABOVITZ, AJ ;
RAICHLEN, JS ;
SCHUTZ, RW ;
SHAH, PM ;
SMITH, MD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1494-1500
[6]   PRINCIPLES AND RECENT DEVELOPMENTS IN ULTRASOUND CONTRAST AGENTS [J].
DEJONG, N ;
TENCATE, FJ ;
LANCEE, CT ;
ROELANDT, JRTC ;
BOM, N .
ULTRASONICS, 1991, 29 (04) :324-330
[7]  
DeMaria AN, 1998, J AM COLL CARDIOL, V32, P1270
[8]   INTRAVENOUS ALBUNEX DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY - ENHANCED LOCALIZATION OF LEFT-VENTRICULAR ENDOCARDIAL BORDERS [J].
FALCONE, RA ;
MARCOVITZ, PA ;
PEREZ, JE ;
DITTRICH, HC ;
HOPKINS, WE ;
ARMSTRONG, WF .
AMERICAN HEART JOURNAL, 1995, 130 (02) :254-258
[9]   SAFETY AND EFFICACY OF A NEW TRANSPULMONARY ULTRASOUND CONTRAST AGENT - INITIAL MULTICENTER CLINICAL-RESULTS [J].
FEINSTEIN, SB ;
CHEIRIF, J ;
TENCATE, FJ ;
SILVERMAN, PR ;
HEIDENREICH, PA ;
DICK, C ;
DESIR, RM ;
ARMSTRONG, WF ;
QUINONES, MA ;
SHAH, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) :316-324
[10]   Phase I clinical trials of MRX-115 - A new ultrasound contrast agent [J].
Fritz, TA ;
Unger, EC ;
Sutherland, G ;
Sahn, D .
INVESTIGATIVE RADIOLOGY, 1997, 32 (12) :735-740